Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Deferred tax assets: | ||
Net operating loss carryforwards | $ 6,890,275 | $ 5,202,047 |
Deferred Tax Assets Capitalized Research And Development | 2,854,530 | 0 |
Stock-based compensation | 2,440,885 | 2,272,970 |
Accrued expenses | 199,961 | 0 |
Total deferred tax assets | 12,385,651 | 7,475,017 |
Deferred tax asset valuation allowance | (12,385,651) | (7,475,017) |
Net deferred tax asset | $ 0 | $ 0 |
X | ||||||||||
- Definition Deferred Tax Assets Accrued Expenses No definition available.
|
X | ||||||||||
- Definition Deferred Tax Assets Capitalized Research And Development No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|